2-Alkyl/arylamino-6-chlorothieno[3,2-e]-1,3-thiazin-3-one derivatives were prepared in one-pot synthesis by refluxing alky/arylisothiocyanates and 2,5-dichloro-3-thiophenecarboxamide. Alternatively, these derivatives were prepared by the intramolecular cyclization of the deprotonated 2,5-dichloro-N-(alkyl/arylaminocarbonothioyl)thiophene-3-carboxamides, which were obtained by the reaction of the deprotonated 2,5-dichloro-3-thiophene-carboxamide with alky/arylisothiocyanates. The structures of the newly synthesized bicyclic derivatives, and their acyclic precursors, were confirmed based on microanalytical and spectral (IR, MS, and NMR) data.
Introduction
Few benzo-and heteroarenes fused to 1,3-thiazine rings, such as pyrido[3,2-e]-1,3-thiazines and thieno[3,2-e]-1,3-thiazines (1-3, Fig. 1 ), are known. [1] [2] [3] [4] [5] [6] [7] [8] locus. [1] [2] [3] [4] [5] The biological activities of these compounds included their use as inhibitor of apoptosis and cytoprotective agent, [1] as heart muscle cell apoptosis inhibitor and remedy for heart diseases, [2] inhibitor on xanthine oxidase, [3] agrochemical fungicide, bronchodilator, phosphordiesterase inhibitor, symptomatic relief in asthma and other respiratory diseases. [5] Pyrido[3,2-e]-1,3-thiazines (2) are 8-aza analogs of 1 and several derivatives have been synthesized and claimed to possess kainic acid neuronotoxicity inhibitory activities. [6, 7] They were established as nervous cell protectors for prevention and treatment of diabetes mellitus, Parkinson disease, psychosis, epilepsy, ischemic brain diseases, multiple scleredema, neuroallergy diseases, Huntington chorea, Alzheimer diseases, drug dependence, and related diseases. [6] From the point of isosterism, the thiophene ring system is commonly used as replacement of the benzene ring in several pharmaceutical agents. In a previous paper, [8] we reported the synthesis of 6-chloro-2-(disubstituted-amino)-thieno 
Experimental

Physical measurements
All analyses were performed at Al al-Bayt University. Melting point was determined on an Electrothermal 9100 melting point apparatus. The nuclear magnetic resonance spectra were acquired with an Ultra-shield FT-NMR Bruker spectrometer (300 MHz). Mass spectra were obtained on GC-MS (EI) spectrometer (Shimadzu, QP-5050A). Elemental analyses were recorded on EA analyzer Euro-vector EA 3000A.
High resolution mass spectra (HRMS) were measured by electrospray ionization (ESI)
technique on a Bruker APEX-2 instrument.
Preparation of 2,5-dichlorothiophene-3-carboxamide (6)
This compound was prepared following literature procedure [8] [9] [10] by the addition of excess amount (35 mL) of ammonium hydroxide solution (25%) to compound 5, m.p. = 104-106 °C, lit. m.p. = 106-108 °C; yield = 85%.
2,5-Dichloro-N-[(Alkyl/arylamino)carbonothioyl]thiophene-3-carboxamide (8a-d)
General Procedure
The desired compounds were prepared by adding sodium hydride (0.40 g, 10 mmol; suspension 60% in oil) portionwise to a solution of 2,5-dichlorothiophene-3-carboxamide (6) (0.98 g, 5 mmol) dissolved in dry THF (20 mL). The reaction mixture was stirred at room temp. for 30 min. After the evolution of H 2 gas has ceased, alkyl/aryl isothiocyanate (5.0 mmol) dissolved in dry THF was added dropwise with intensive stirring.
After the addition was completed, the reaction mixture was stirred at room temperature for 24 h; glacial acetic acid (5 mL) was then added. The solvent was evaporated using rotary evaporator; the remaining solid was extracted with diethyl ether and evaporated under vacuum. Extra purification was performed by TLC Plates using Silica gel (UV active, 245 nm) with chloroform as a developing solvent (eluent).
The following compounds were obtained.
2,5-Dichloro-N-(ethylcarbamothioyl)thiophene-3-carboxamide (8a)
A yellowish brown precipitate; yield ( 
2,5-Dichloro-N-(cyclohexylcarbamothioyl)thiophene-3-carboxamide (8b)
2,5-Dichloro-N-(methylcarbamothioyl)thiophene-3-carboxamide (8d)
A pale yellow precipitate; yield (0.75 g, 55%); m. 
6-Chloro-2-(Alkyl/arylamino)-thieno[3,2-e][1,3]thiazin-4-one (4a-c) General procedure (one-pot synthesis)
The desired compounds were prepared by adding sodium hydride (0.4 g, 10 mmol, suspension 60% in oil) portionwise to a solution of 2,5-dichlorothiophene-3-carboxamide (6) (0.98 g, 5 mmol) dissolved in dry THF (20 mL). The reaction mixture was stirred at room temperature for 30 min, then after the evolution of H 2 gas has ceased, the alkyl/arylisothiocyanates (5.0 mmol) dissolved in dry DMF (20 mL) was added dropwise with intensive stirring. After the addition was completed, the reaction mixture was refluxed for 24 h (the progress of the reaction was followed by TLC using chloroform as eluent, the thin layer chromatography showed that the product is a mixture of the title compounds 4 and 8 in which the open compound 8 shows higher R f value as compared to the cyclic compounds 4). After the completion of the reaction, glacial acetic acid (5 mL) was added. The solvent was evaporated by rotary evaporator, and then the remaining solid was extracted with diethyl ether and evaporated under vacuum. Extra purification was performed by TLC Plate using Silica gel (UV active, 245 nm) with chloroform as an eluent. The following products were obtained by the above general procedure: [3,2- The title compounds where prepared by the dropwise addition with stirring of sodium hydride to the respective carboxamide (1:1 mole ratio) dissolved in THF at room temperature. The reaction mixture was stirred at room temperature for 30 min, then after the evolution of H 2 gas has ceased, the reaction mixture was refluxed for 24 h (the progress of the reaction was followed by TLC using chloroform as eluent). The products were isolated as shown in the previous procedure.
6-Chloro-2-(ethyl amino)-thieno
